Fibroblast growth factor-1 within the ventral tegmental area participates in motor sensitizing effects of morphine

Neuroscience

Volumn 165, Issue 1, 2010, Pages 198-211

  Flores, J A ^a   Galan Rodriguez, B ^a   Rojo, A I ^b   Ramiro Fuentes, S ^a   Cuadrado, A ^b   Fernandez Espejo, E ^a  

^a UNIVERSITY OF SEVILLE   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED SOBRE ENFERMEDADES NEURODEGENERATIVAS CIBERNED   (Spain)

Author keywords

astrocyte; FGF 1; FGFR 1; morphine; sensitization; ventral tegmental area

Indexed keywords

CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; FIBROBLAST GROWTH FACTOR 1; FIBROBLAST GROWTH FACTOR RECEPTOR 1; MORPHINE SULFATE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 1; TYROSINE 3 MONOOXYGENASE;

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; ENZYME ACTIVATION; ENZYME REGULATION; GABAERGIC SYSTEM; MALE; MORPHINE ADDICTION; MOTOR PERFORMANCE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RECEPTOR UPREGULATION; SENSITIZATION; SUBSTANTIA NIGRA; VENTRAL TEGMENTUM;

EID: 70449630849     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2009.10.009     Document Type: Article

References (65)

1. Acquas A., and Di Chiara G. Depression of mesolimbic dopamine transmission and sensitization to morphine during opiate abstinence. J Neurochem 58 5 (1992) 1620-1625
2. Bean A.J., Elde R., Cao Y.H., Oellig C., Tamminga C., Goldstein M., Pettersson R.F., and Hökfelt Y. Expression of acidic and basic fibroblast growth factors in the substantia nigra of rat, monkey, and human. Proc Natl Acad Sci U S A 88 22 (1991) 10237-10241
3. Beitner-Johnson D., and Nestler E.J. Morphine and cocaine exert common chronic actions on tyrosine hydroxylase in dopamine brain reward regions. J Neurochem 57 (1991) 344-347
4. Belcheva M.M., Haas P.D., Tan Y., Heaton V.M., and Coscia C.J. The fibroblast growth factor receptor is at the site of convergence between Mu-opioid receptor and growth factor signaling pathways in rat C6 glioma cells. J Pharmacol Exp Ther 303 3 (2002) 909-918
5. Belluardo N., Wu G., Mudo G., Hansson A.C., Petterson R., and Fuxe K. Comparative localization of fibroblast growth factor receptor-1, -2 and -3 mRNAs in the rat brain: in situ hybridization analysis. J Comp Neurol 379 (1997) 226-246
6. Berhow M.T., Hiroi N., and Nestler E.J. Regulation of ERK (extracellular signal regulated kinase), part of the neurotrophin signal transduction cascade, in the rat mesolimbic dopamine system by chronic exposure to morphine or cocaine. J Neurosci 16 (1996) 4707-4715
7. Berhow M.T., Russell D.S., Terwilliger R.Z., Beitner-Johnson D., Self D.W., Lindsay R.M., and Nestler E.J. Influence of neurotrophic factors on morphine- and cocaine-induced biochemical changes in the mesolimbic dopamine system. Neuroscience 68 (1995) 969-979
8. Boundy V.A., Gold S.J., Messer C.J., Chen J., Son J.H., Joh T.H., and Nestler E.J. Regulation of tyrosine hydroxylase promoter activity by chronic morphine in TH90-LacZ transgenic mice. J Neurosci 18 (1998) 9989-9995
9. Burke R.E., Antonelli M., and Sulzer D. Glial cell line-derived neurotrophic growth factor inhibits apoptotic death of postnatal substantia nigra dopamine neurons in primary culture. J Neurochem 71 (1998) 517-525
10. Cardozo D.L. Midbrain dopaminergic neurons from postnatal rat in long-term primary culture. Neuroscience 56 2 (1993) 409-421
11. Carlezon W.A., Boundy V.A., Haile C.N., Lane S.B., Kalb R.G., Neve R.L., and Nestler E.J. Sensitization to morphine induced by viral-mediated gene transfer. Science 277 (1997) 812-814
12. Di Chiara G., and Imperato A. Drugs of abuse preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci U S A 85 (1988) 5274-5278
13. 1-expressing extra-adrenal chromaffin cells of the Zuckerkandl's organ. J Neurosci 21 (2001) 9888-9895
14. Fitzgerald L.W., Ortiz J., Hamedani A.G., and Nestler E.J. Drugs of abuse and stress increase the expression of GluR1 and NMDAR1 glutamate receptor subunits in the rat ventral tegmental area: common adaptations among cross-sensitizing agents. J Neurosci 16 (1996) 274-282
15. Flores C., Rodaros D., and Stewart J. Long-lasting induction of astrocytic basic fibroblast growth factor by repeated injections of amphetamine: blockade by concurrent treatment with a glutamate antagonist. J Neurosci 18 (1998) 9547-9555
16. Flores C., Samaha A.N., and Stewart J. Requirement of endogenous basic fibroblast growth factor for sensitization to amphetamine. J Neurosci 20 2 (2000) RC55
17. Flores C., and Stewart J. Basic fibroblast growth factor as a mediator of the effects of glutamate in the development of long-lasting sensitization to stimulant drugs: studies in the rat. Psychopharmacology 151 (2000) 152-165
18. Flores J.A., Galan-Rodriguez B., Ramiro-Fuentes S., and Fernandez-Espejo E. Role for dopamine neurons of the anterior linear nucleus and periaqueductal grey in the rewarding and sensitizing properties of heroin. Neuropsychopharmacology 31 (2006) 1475-1488
19. Gonzalez A.M., Berry M., Maher P.A., Logan A., and Baird A. A comprehensive analysis of the distribution of FGF-2 and FGFR-1 in the rat brain. Brain Res 701 (1995) 201-226
20. Hisajima H., Saito H., Abe K., and Nishiyama N. Effects of acidic fibroblast growth factor on hippocampal long-term potentiation in fasted rats. J Neurosci Res 31 (1992) 549-553
21. Hope B.T., Nye H.E., Kelz M.B., Self D.W., Iadarola M.J., Nakabeppu Y., Duman R.S., and Nestler E.J. Induction of a long-lasting AP-1 complex composed of altered Fos-like proteins in brain by chronic cocaine and other chronic treatments. Neuron 13 (1994) 1235-1244
22. Kelley A.E. Memory and addiction: shared neural circuitry and molecular mechanisms. Neuron 44 (2004) 161-179
23. Klejbor I., Myers J.M., Hausknecht K., Corso T.D., Gambino A.S., Morys J., Maher P.A., Hard R., Richards J., Stachowiak E.K., and Stachowiak M.K. Fibroblast growth factor receptor signaling affects development and function of dopamine neurons-inhibition results in a schizophrenia-like syndrome in transgenic mice. J Neurochem 97 (2006) 1243-1258
24. Koob G.F., and Bloom F.E. Cellular and molecular mechanisms of drug dependence. Science 242 (1988) 715-723
25. Koob G.F., Vaccarino F.J., Amalric M., and Bloom F.E. Neurochemical substrates for opiate reinforcement. NIDA Res Monogr 71 (1986) 146-164
26. Kruger G.M., Mosher J.T., Bixby S., Joseph N., Iwashita T., and Morrison S.J. Neural crest stem cells persist in the adult gut but undergo changes in self-renewal, neuronal subtype potentials and factor responsiveness. Neuron 35 (2002) 657-669
27. Kumer S.C., and Vrana K.E. Intrincate regulation of tyrosine hydroxylase activity and gene expression. J Neurochem 67 (1996) 443-462
28. Licata S.C., and Pierce R.C. The roles of calcium/calmodulin-dependent and Ras/mitogen-activated protein kinases in the development of psychostimulant-induced behavioral sensitization. J Neurochem 85 (2003) 14-22
29. Liu X., and Zhu X.Z. Increased expression and nuclear accumulation of basic fibroblast growth factor in primary cultured astrocytes following ischemic-like insults. Brain Res Mol Brain Res 71 (1999) 171-177
30. Mena M.A., Davila V., and Sulzer D. Neurotrophic effects of L-DOPA in postnatal midbrain dopamine neuron/cortical astrocyte cocultures. J Neurochem 69 (1997) 1398-1408
31. Messer C.J., Eisch A.J., Carlezon Jr. W.A., Whisler K., Shen L., Wolf D.H., Westphal H., Collins F., Russell D.S., and Nestler E.J. Role for GDNF in biochemical and behavioral adaptations to drugs of abuse. Neuron 26 (2000) 247-257
32. Muller D.L., and Unterwald E.M. D1 dopamine receptors modulate ΔFosβ induction in rat striatum after intermittent moprhine administration. J Pharmacol Exp Ther 314 (2005) 148-154
33. Nestler E.J. Molecular basis of long-term plasticity underlying addiction. Nat Rev Neurosci 2 (2001) 119-128
34. Nestler E.J. Is there a common molecular pathway for addiction?. Nat Neurosci 8 (2005) 1445-1449
35. Nestler E.J., and Aghajanian G.K. Molecular and cellular basis of addiction. Science 278 (1997) 58-63
36. Noble M., and Mayer-Pröshcel M. Culture of astrocytes, oligodendrocytes, and O-2A progenitor cells. In: Banker G., and Goslin K. (Eds). Culturing nerve cells (1998), MIT Press, Cambridge, MA 499-544
37. Nye H.E., and Nestler E.J. Induction of chronic Fos-related antigens in rat brain by chronic morphine administration. Mol Pharmacol 49 (1996) 636-645
38. Paxinos G., and Watson C. The rat brain in stereotaxic coordinates (2005), Elsevier, Amsterdam
39. Reuss B., Leung D.S., Ohlemeyer C., Kettenmann H., and Unsicker K. Regionally distinct regulation of astroglial neurotransmitter receptor by fibroblast growth factor-2. Mol Cell Neurosci 16 (2000) 42-58
40. Reuss B., and von Bohlen und Halbach O. Fibroblast growth factors and their receptors in the central nervous system. Cell Tissue Res 313 (2003) 139-157
41. Robinson T.E., and Berridge K.C. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Rev 18 (1993) 247-291
42. Salinas M., Wang J., Rosa de Sagarra M., Martín D., Rojo A.I., Martin-Perez J., Ortiz de Montellano P.R., and Cuadrado A. Protein kinase Akt/PKB phosphorylates heme oxygenase-1 in vitro and in vivo. FEBS Lett 578 (2004) 90-94
43. Sasaki K., Oomura Y., Figurov A., and Yagi H. Acidic fibroblast growth factor facilitates generation of long-term potentiation in rat hippocampal slices. Brain Res Bull 33 (1994) 505-511
44. Schoffelmeer A.N., Voorn P., Jonker A.J., Wardeh G., Nestby P., Vanderschuren L.J., De Vries T.J., Mulder A.H., and Tjon G.H. Morphine-induced increase in D-1 receptor regulated signal transduction in rat striatal neurons and its facilitation by glucocorticoid receptor activation: possible role in behavioral sensitization. Neurochem Res 21 11 (1996) 1417-1423
45. Self D.W., and Nestler E.J. Molecular mechanisms of drug reinforcement and addiction. Annu Rev Neurosci 18 (1995) 463-495
46. Sklair-Tavron L., Shi W.X., Lane S.B., Harris H.W., Bunney B.S., and Nestler E.J. Chronic morphine induces visible changes in the morphology of mesolimbic dopamine neurons. Proc Natl Acad Sci U S A 93 (1996) 11202-11207
47. Smeyne M., and Smeyne R.J. Method for culturing postnatal substantia nigra as an in vitro model of experimental Parkinson's disease. Brain Res Brain Res Protoc 9 (2002) 105-111
48. Sorg B.A., Chen S.Y., and Kalivas P.W. Time course of tyrosine hydroxylase expression after behavioral sensitization to cocaine. J Pharmacol Exp Ther 266 (1993) 424-430
49. Spanagel R., Almeida O.F., and Shippenburg T.S. Long-lasting changes in morphine-induced mesolimbic dopamine release after chronic morphine exposure. Synapse 14 (1993) 243-245
50. Stachowiak M.K., Maher P.A., Joy A., Mordechai E., and Stachowiak E.K. Nuclear localization of functional FGF receptor 1 in human astrocytes suggests a novel mechanism to growth factor action. Mol Brain Res 38 (1996) 161-165
51. Stachowiak M.K., Moffett J., Maher P.A., Tucholski J., and Stachowiak E.K. Growth factor regulation of cell growth and proliferation in the nervous system: a new intracrine nuclear mechanism. Mol Neurobiol 15 (1997) 1-27
52. Stock A., Kuzis K., Woodward W.R., Nishi R., and Eckenstein F.P. Localization of acidic fibroblast growth factor in specific subcortical neuronal populations. J Neurosci 12 (1992) 4688-4700
53. Stull N.D., and Iacovitti L. Acidic fibroblast growth factor and catecholamines synergistically up-regulate tyrosine hydroxylase activity in developing and damaged dopamine neurons in culture. J Neurochem 67 (1996) 1519-1524
54. Takami K., Matsuo A., Terai K., Walker D.G., McGeer E.G., and McGeer P.L. Fibroblast growth factor receptor-1 expression in the cortex and hippocampus in Alzheimer's disease. Brain Res 802 (1998) 89-97
55. Terwilliger R.Z., Beitner-Johnson D., Sevarino K.A., Crain S.M., and Nestler E.J. A general role for adaptations in G-proteins and the cyclic AMP system in mediating the chronic actions of morphine and cocaine on neuronal function. Brain Res 548 (1991) 100-110
56. Ujike K., Takaki M., Kodama M., and Kuroda S. Gene expression related to synaptogenesis, neuritogenesis, and MAP kinase in behavioral sensitization to psychostimulants. Ann NY Acad Sci 965 (2002) 55-67
57. Vanderschuren L.J., and Kalivas P.W. Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioural sensitization: a critical review of preclinical studies. Psychopharmacology (Berl) 151 (2000) 99-120
58. Vezina P., and Stewart J. The effect of dopamine receptor blockade on the development of sensitization to the locomotor activating effects of amphetamine and morphine. Brain Res 499 (1989) 108-120
59. Vigano D., Rubino T., Di Chiara G., Ascari I., Massi P., and Parolaro D. Mu opioid receptor signaling in morphine sensitization. Neuroscience 117 (2003) 921-929
60. Vrana S.L., Vrana K.E., Koves T.R., Smith J.E., and Dworkin S.I. Chronic cocaine administration increases CNS tyrosine hydroxylase enzyme activity and mRNA levels and tryptophan hydroxylase enzyme activity levels. J Neurochem 61 (1993) 2262-2268
61. Wilcox B.J., and Unnerstall J.R. Expression of acidic fibroblast growth factor mRNA in the developing and adult rat brain. Neuron 6 (1991) 397-409
62. Williams J.T., Christie M.J., and Manzoni O. Cellular and synaptic adaptations mediating opioid dependence. Physiol Rev 81 (2001) 299-343
63. Wise R.A. Addiction becomes a brain disease. Neuron 26 (2000) 27-33
64. Wise R.A., and Rompre P.P. Brain dopamine and reward. Annu Rev Psychol 40 (1989) 191-225
65. Yazaki N., Hosoi Y., Kawabata K., Miyake A., Minami M., Satoh M., Ohta M., Kawasaki T., and Itoh N. Differential expression patterns of mRNAs members of the fibroblast growth factor receptor family, FGFR-1-FGFR-4, in at brain. J Neurosci Res 37 (1994) 445-452